[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100525446":3},{"organization":4,"armGroups":7,"interventions":31,"overallOfficials":70,"centralContacts":74,"locations":82,"responsibleParty":333,"collaborators":11,"id":335,"slug":336,"hasResults":337,"nctId":338,"briefTitle":339,"officialTitle":340,"acronym":11,"eligibilityCriteria":341,"healthyVolunteers":337,"sex":342,"minAge":343,"maxAge":11,"enrollmentInfo":344,"targetDuration":11,"studyType":347,"phases":348,"briefSummary":350,"conditions":351,"keywords":353,"overallStatus":85,"whyStopped":11,"lastUpdateSubmitDate":364,"lastUpdatePostDateStruct":365,"startDateStruct":368,"completionDateStruct":370,"leadSponsor":372,"locationsCount":373},{"fullName":5,"class":6},"Juno Therapeutics, Inc., a Bristol-Myers Squibb Company","INDUSTRY",[8,15,19,23,27],{"label":9,"type":10,"description":11,"interventionNames":12},"Arm A: BMS-986393 + Alnuctamab","EXPERIMENTAL",null,[13,14],"Drug: BMS-986393","Drug: Alnuctamab",{"label":16,"type":10,"description":11,"interventionNames":17},"Arm B: BMS-986393 + Mezigdomide",[13,18],"Drug: Mezigdomide",{"label":20,"type":10,"description":11,"interventionNames":21},"Arm C: BMS-986393 + Iberdomide",[13,22],"Drug: Iberdomide",{"label":24,"type":10,"description":11,"interventionNames":25},"Arm D: BMS-986393 + Elranatamab",[13,26],"Drug: Elranatamab",{"label":28,"type":10,"description":11,"interventionNames":29},"Arm E: BMS-986393 + Mezigdomide and Dexamethasone",[13,18,30],"Drug: Dexamethasone",[32,41,48,54,60,65],{"type":33,"name":34,"description":35,"armGroupLabels":36,"otherNames":37},"DRUG","BMS-986393","Specified dose on specified days",[9,16,20,24,28],[38,39,40],"CC-95266","Arlocabtagene autoleucel","arlo-cel",{"type":33,"name":42,"description":35,"armGroupLabels":43,"otherNames":44},"Alnuctamab",[9],[45,46,47],"BMS-986349","CC-93269","EM901",{"type":33,"name":49,"description":35,"armGroupLabels":50,"otherNames":51},"Mezigdomide",[16,28],[52,53],"BMS-986348","CC-92480",{"type":33,"name":55,"description":35,"armGroupLabels":56,"otherNames":57},"Iberdomide",[20],[58,59],"BMS-986382","CC-220",{"type":33,"name":61,"description":35,"armGroupLabels":62,"otherNames":63},"Elranatamab",[24],[64],"Elrexfio",{"type":33,"name":66,"description":35,"armGroupLabels":67,"otherNames":68},"Dexamethasone",[28],[69],"Decadron",[71],{"name":72,"affiliation":72,"role":73},"Bristol-Myers Squibb","STUDY_DIRECTOR",[75,80],{"name":76,"role":77,"phone":78,"phoneExt":11,"email":79},"BMS Clinical Trials Contact Center www.BMSClinicalTrials.com","CONTACT","855-907-3286","Clinical.Trials@bms.com",{"name":81,"role":77,"phone":11,"phoneExt":11,"email":11},"First line of the email MUST contain NCT # and Site #.",[83,101,115,129,143,157,171,180,193,207,221,235,247,254,264,275,289,303,319],{"facility":84,"status":85,"city":86,"state":87,"zip":88,"country":89,"countryCode":90,"cosmosGeoPoint":91,"geoPoint":96,"contacts":97},"University of Alabama at Birmingham","RECRUITING","Birmingham","Alabama","35294-3300","United States","US",{"type":92,"coordinates":93},"Point",[94,95],-86.80249,33.52066,{"lat":95,"lon":94},[98],{"name":99,"role":77,"phone":100,"phoneExt":11,"email":11},"Susan Bal, Site 0008","205-934-1908",{"facility":102,"status":85,"city":103,"state":104,"zip":105,"country":89,"countryCode":90,"cosmosGeoPoint":106,"geoPoint":110,"contacts":111},"Mayo Clinic in Arizona - Phoenix","Phoenix","Arizona","85054",{"type":92,"coordinates":107},[108,109],-112.07404,33.44838,{"lat":109,"lon":108},[112],{"name":113,"role":77,"phone":114,"phoneExt":11,"email":11},"Julia Wiedmeier-Nutor, Site 0002","855-776-0015",{"facility":116,"status":85,"city":117,"state":118,"zip":119,"country":89,"countryCode":90,"cosmosGeoPoint":120,"geoPoint":124,"contacts":125},"City of Hope Comprehensive Cancer Center","Duarte","California","91010",{"type":92,"coordinates":121},[122,123],-117.97729,34.13945,{"lat":123,"lon":122},[126],{"name":127,"role":77,"phone":128,"phoneExt":11,"email":11},"Myo Htut, Site 0028","626-256-4673",{"facility":130,"status":85,"city":131,"state":132,"zip":133,"country":89,"countryCode":90,"cosmosGeoPoint":134,"geoPoint":138,"contacts":139},"Mayo Clinic in Florida","Jacksonville","Florida","32224",{"type":92,"coordinates":135},[136,137],-81.65565,30.33218,{"lat":137,"lon":136},[140],{"name":141,"role":77,"phone":142,"phoneExt":11,"email":11},"Sikander Ailawadhi, Site 0005","904-953-0853",{"facility":144,"status":85,"city":145,"state":146,"zip":147,"country":89,"countryCode":90,"cosmosGeoPoint":148,"geoPoint":152,"contacts":153},"Northside Hospital","Atlanta","Georgia","30342",{"type":92,"coordinates":149},[150,151],-84.38798,33.749,{"lat":151,"lon":150},[154],{"name":155,"role":77,"phone":156,"phoneExt":11,"email":11},"Scott Solomon, Site 0006","404-255-1930",{"facility":158,"status":85,"city":159,"state":160,"zip":161,"country":89,"countryCode":90,"cosmosGeoPoint":162,"geoPoint":166,"contacts":167},"Beth Israel Deaconess Medical Center","Boston","Massachusetts","02215",{"type":92,"coordinates":163},[164,165],-71.05977,42.35843,{"lat":165,"lon":164},[168],{"name":169,"role":77,"phone":170,"phoneExt":11,"email":11},"Jacalyn Rosenblatt, Site 0027","617-667-9920",{"facility":172,"status":85,"city":159,"state":160,"zip":161,"country":89,"countryCode":90,"cosmosGeoPoint":173,"geoPoint":175,"contacts":176},"Dana-Farber Cancer Institute",{"type":92,"coordinates":174},[164,165],{"lat":165,"lon":164},[177],{"name":178,"role":77,"phone":179,"phoneExt":11,"email":11},"Omar Nadeem, Site 0011","617-632-3000",{"facility":181,"status":85,"city":182,"state":183,"zip":184,"country":89,"countryCode":90,"cosmosGeoPoint":185,"geoPoint":189,"contacts":190},"Mayo Clinic in Rochester, Minnesota","Rochester","Minnesota","55905",{"type":92,"coordinates":186},[187,188],-92.4699,44.02163,{"lat":188,"lon":187},[191],{"name":192,"role":77,"phone":114,"phoneExt":11,"email":11},"Taxiarchis Kourelis, Site 0001",{"facility":194,"status":85,"city":195,"state":196,"zip":197,"country":89,"countryCode":90,"cosmosGeoPoint":198,"geoPoint":202,"contacts":203},"University Of Nebraska Medical Center","Omaha","Nebraska","68198",{"type":92,"coordinates":199},[200,201],-95.94043,41.25626,{"lat":201,"lon":200},[204],{"name":205,"role":77,"phone":206,"phoneExt":11,"email":11},"Christopher D'Angelo, Site 0010","402-559-8110",{"facility":208,"status":85,"city":209,"state":210,"zip":211,"country":89,"countryCode":90,"cosmosGeoPoint":212,"geoPoint":216,"contacts":217},"John Theurer Cancer Center at Hackensack University Medical Center","Hackensack","New Jersey","07601-2191",{"type":92,"coordinates":213},[214,215],-74.04347,40.88593,{"lat":215,"lon":214},[218],{"name":219,"role":77,"phone":220,"phoneExt":11,"email":11},"David Siegel, Site 0004","551-996-8704",{"facility":222,"status":85,"city":223,"state":224,"zip":225,"country":89,"countryCode":90,"cosmosGeoPoint":226,"geoPoint":230,"contacts":231},"Roswell Park Cancer Institute","Buffalo","New York","14263",{"type":92,"coordinates":227},[228,229],-78.87837,42.88645,{"lat":229,"lon":228},[232],{"name":233,"role":77,"phone":234,"phoneExt":11,"email":11},"Ehsan Malek, Site 0007","216-286-4441",{"facility":236,"status":85,"city":224,"state":224,"zip":237,"country":89,"countryCode":90,"cosmosGeoPoint":238,"geoPoint":242,"contacts":243},"Laura and Isaac Perlmutter Cancer Center","10016",{"type":92,"coordinates":239},[240,241],-74.00597,40.71427,{"lat":241,"lon":240},[244],{"name":245,"role":77,"phone":246,"phoneExt":11,"email":11},"Jingmei Hsu, Site 0022","646-501-4848",{"facility":248,"status":249,"city":224,"state":224,"zip":250,"country":89,"countryCode":90,"cosmosGeoPoint":251,"geoPoint":253,"contacts":11},"Local Institution - 0009","COMPLETED","10032",{"type":92,"coordinates":252},[240,241],{"lat":241,"lon":240},{"facility":255,"status":85,"city":224,"state":224,"zip":256,"country":89,"countryCode":90,"cosmosGeoPoint":257,"geoPoint":259,"contacts":260},"Memorial Sloan Kettering Cancer Center","10065",{"type":92,"coordinates":258},[240,241],{"lat":241,"lon":240},[261],{"name":262,"role":77,"phone":263,"phoneExt":11,"email":11},"Sham Mailankody, Site 0012","646-608-3712",{"facility":265,"status":266,"city":267,"state":268,"zip":269,"country":89,"countryCode":90,"cosmosGeoPoint":270,"geoPoint":274,"contacts":11},"Local Institution - 0023","WITHDRAWN","Pittsburgh","Pennsylvania","15232",{"type":92,"coordinates":271},[272,273],-79.99589,40.44062,{"lat":273,"lon":272},{"facility":276,"status":85,"city":277,"state":278,"zip":279,"country":89,"countryCode":90,"cosmosGeoPoint":280,"geoPoint":284,"contacts":285},"Tennessee Oncology","Nashville","Tennessee","37203",{"type":92,"coordinates":281},[282,283],-86.78444,36.16589,{"lat":283,"lon":282},[286],{"name":287,"role":77,"phone":288,"phoneExt":11,"email":11},"Jesus Berdeja, Site 0025","615-329-0570",{"facility":290,"status":85,"city":291,"state":292,"zip":293,"country":89,"countryCode":90,"cosmosGeoPoint":294,"geoPoint":298,"contacts":299},"University of Texas MD Anderson Cancer Center","Houston","Texas","77030",{"type":92,"coordinates":295},[296,297],-95.36327,29.76328,{"lat":297,"lon":296},[300],{"name":301,"role":77,"phone":302,"phoneExt":11,"email":11},"Krina Patel, Site 0003","713-792-6662",{"facility":304,"status":85,"city":305,"state":306,"zip":307,"country":308,"countryCode":309,"cosmosGeoPoint":310,"geoPoint":314,"contacts":315},"Arthur J.E. Child Comprehensive Cancer Centre","Calgary","Alberta","T2N 5G2","Canada","CA",{"type":92,"coordinates":311},[312,313],-114.08529,51.05011,{"lat":313,"lon":312},[316],{"name":317,"role":77,"phone":318,"phoneExt":11,"email":11},"Nizar Bahlis, Site 0013","4032202801",{"facility":320,"status":85,"city":321,"state":322,"zip":323,"country":308,"countryCode":309,"cosmosGeoPoint":324,"geoPoint":328,"contacts":329},"Princess Margaret Cancer Centre","Toronto","Ontario","M5G 2M9",{"type":92,"coordinates":325},[326,327],-79.39864,43.70643,{"lat":327,"lon":326},[330],{"name":331,"role":77,"phone":332,"phoneExt":11,"email":11},"Christine Chen, Site 0024","4169464501",{"type":334,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100525446","phase-1-a-study-to-evaluate-the-safety-effectiveness-and-tolerable-dose-of-arlocabtagene-autoleucel-bms-986393-in-novel-combinations-in-participants-with-relapsed-andor-refractory-multiple-myeloma-100525446",false,"NCT06121843","A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and\u002For Refractory Multiple Myeloma","A Phase 1, Multicenter, Open-label Study to Evaluate the Safety and Preliminary Efficacy of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and\u002For Refractory Multiple Myeloma and Determine the Recommended Dose for Each Add-on Investigational Component","Inclusion Criteria:\n\n* History of relapsed and\u002For refractory multiple myeloma (RRMM) treated with at least 3 (Part 1), history of RRMM or at least 1 but not greater than 3 prior anti-myeloma treatment (PAMT) regimens (Part 2, Arms A, B, C, and D); history of quadruple class exposed RRMM having received BCMA TCE as the most recent line of therapy (Part 2, Arm E).\n* Measurable multiple myeloma (MM) as per International Myeloma Working Group (IMWG).\n* Eastern Cooperative Oncology Group performance status of 0-1.\n* Adherence to contraception requirements.\n\nExclusion Criteria:\n\n* Prior treatment with alnuctamab (Arm A), mezigdomide (Arms B and E), iberdomide (Arm C), elranatamab (Arm D) or BCMA-targeting therapy (Part 2 Arms A and D).\n* Prior treatment with GPRC5D-targeting therapies as of Protocol Amendment 02 (Part 1 and Part 2).\n* Other protocol-defined inclusion\u002Fexclusion criteria apply.","ALL","18 Years",{"count":345,"type":346},187,"ESTIMATED","INTERVENTIONAL",[349],"PHASE1","The purpose of this study is to establish a safe and tolerable dose of arlocabtagene autoleucel (BMS-986393) in combinations with alnuctamab, mezigdomide, iberdomide, and elranatamab in participants with relapsed and\u002For refractory multiple myeloma (RRMM).",[352],"Multiple Myeloma",[34,354,355,356,42,49,55,38,357,358,359,360,361,362,363,40],"Relapsed Multiple Myeloma","Refractory Multiple Myeloma","First-in-human","GPRC5D","GPRC5D CAR T","Cell Therapy","CAR T cell therapy","Combination therapy","elranatamab","arlocabtagene autoleucel","2026-07-15",{"date":366,"type":367},"2026-07-16","ACTUAL",{"date":369,"type":367},"2024-02-22",{"date":371,"type":346},"2028-08-01",{"name":5,"class":6},19]